Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842062 · ClinicalTrials.gov registry record · Phase 1
Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation
A Phase 1 study of Facial Rhytides, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 380
- Enrollment target
- 1
- Study location
NCT00842062: Completed Phase 1 study of Facial Rhytides, sponsored by Pacira Pharmaceuticals.
NCT00842062 is a Phase 1 study of Facial Rhytides that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 380 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (533% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842062, a Phase 1 study of Facial Rhytides, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 380 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's feet), and frontalis lines (horizontal forehead lines).
Conditions Studied
Interventions
- DEVICE MyoScience Tissue Remodeling Device
Study Locations (1)
California
- The Aesthetics Research Center - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
What the finished NCT00842062 record still lists
NCT00842062 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (533% higher).
The record links to 1 condition, with Facial Rhytides appearing as the primary indexed condition, and to 1 intervention - of which MyoScience Tissue Remodeling Device is the first listed.
NCT00842062 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00842062 about?
NCT00842062 is a clinical study titled "Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation". A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's feet), and frontalis lines (horizontal forehead lines).
What is the current status of trial NCT00842062?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 380 participants. The study started on 2009-02. Estimated completion is 2012-01.
What conditions does trial NCT00842062 study?
This clinical trial studies the following conditions: Facial Rhytides.
What interventions are being tested in trial NCT00842062?
The interventions under investigation include: MyoScience Tissue Remodeling Device (DEVICE).
Who is sponsoring clinical trial NCT00842062?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00842062 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Rhytides
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00842062's enrollment target sits among peer trials
380 81st of 2000 higher than 1,917 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia